Some private insurers might bundle 96372 into the office visit regardless of modifiers, while others follow [CMS guidelines] strictly
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. Eventide: Biomedicine & Pharmacotherapy (2018)
Designed to inhibit DPP-4, the enzyme found to degrade GLP-1 (7-37), this drug, generically called sitagliptin, was developed at Merck by its first research team solely led by women
Variability in Effectiveness : Because compounded medications are custom-made, there can be variability in their dose strengths
Key symptoms Persistent feeling of queasiness or the urge to vomit Increased salivation (watering mouth) Retching or dry heaving Actual vomiting of stomach contents Loss of appetite Potential dehydration if vomiting is severe How common are nausea and vomiting with GLP-1 treatments
If Vendor A charges $80 for a 10mg vial that independently tests at 99% purity with accurate fill weight, the cost per active milligram is approximately $8.08